Stock screenerAll disclosures →
EDGAR →
MIRM
Conviction 94HealthcareScan · Thu, Jun 25, 2026MIRM$117.23+1.97%
ResistanceSupportVol 14Insider sell3
7
Vol MA14 962.41K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price117.23
Change+1.97%
Gap-1.58%
Rel volume1.70×
Avg volume897.89K
Avg $ vol92.27M
SMA 20100.61
SMA 5099.90
SMA 20086.91
Price vs 50+17.35%
Price vs 200+34.89%
MA stackbullish
50/200 cross—
Supertrendup · 101.31
RSI (14)75
MACD hist2.21
MACD crossbull · 8d
Stoch %K / %D92 / 96
ADX (14)23
+DI / −DI33 / 11
RSI divergence—
MACD divergence—
ATR %+4.25%
ADR %4.45%
52w high117.23
52w low48.39
From 52w high+0.00%
Above 52w low+142.26%
New 52w highYes
SqueezeOff
Bollinger width29.43%
%B1.06
Donchian pos92.21%
Donchian high119.48
Donchian low90.59
AVWAP (52w high)116.62
vs AVWAP high+0.52%
AVWAP (52w low)84.95
vs AVWAP low+38.00%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d1.70×
Avg vol (14d)962.41K
Avg vol (20d)897.89K
Avg $ vol (20d)92.27M
Market cap7.15B
RS 3m (vs SPY)+18.57%
RS 6m (vs SPY)+40.15%
RS line new highYes
Trend template8/8
Technical rank91.9
1 week+14.89%
1 month+18.53%
3 months+30.01%
6 months+44.60%
1 year+129.37%
YTD+50.16%
P/E-305.99
P/B29.48
P/S13.71
P/FCF130.28
EPS-0.4700
Div yield—
ROE-9.63%
ROA-2.62%
Debt/Eq—
Current2.09
EV/EBITDA—
Gross margin—
Net margin-4.48%
Rev growth54.74%
EPS growth73.43%
Price target145.36
Target upside24.00%
Analyst ratingBuy
Institutional117.66%
Ent. value6.82B
Revenue159.88M
Net income-790.15M
Gross profit—
Free cash flow54.87M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.98M
Employees418
ListedThu, Jul 18, 2019
Free float48.8M
Float %80.9%
Short interest6.56M
Days to cover7.9d
Short volume81.9%
Squeeze score82 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.77 · 5 est
Last EPS vs est−$0.39 vs −$0.40
Last surprise+2.5% beat
Setup gradeA+
Conviction94 / 100
Pattern quality—
Tech rank91.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance113.50
Support89.46
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MIRM
No recent disclosed trades by Congress in MIRM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MIRM · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Howe Jolanda SVP, GLOBAL CONTROLLER · Common Stock · 2026-06-17 | Sell | 2.59K | $264K | 2026-06-17 | 2026-06-18 |
Brege Laura Director · Deferred Stock Units · 2026-06-15 | Grant | 1.98K | — | 2026-06-15 | 2026-06-17 |
Brege Laura Director · Stock Option (right to buy) · 2026-06-15 | Grant | 3.77K | — | 2026-06-15 | 2026-06-17 |
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-09 | Exercise | 2.39K | $63K | 2026-06-09 | 2026-06-09 |
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER · Employee Stock Option (right to buy) · 2026-06-09 | Exercise | 2.39K | $0 | 2026-06-09 | 2026-06-09 |
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-08 | Sell | 1.57K | $149K | 2026-06-08 | 2026-06-09 |
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-08 | Sell | 1.18K | $110K | 2026-06-08 | 2026-06-09 |
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-08 | Sell | 2.26K | $210K | 2026-06-08 | 2026-06-09 |
Radovich Peter PRESIDENT AND COO · Common Stock · 2026-06-05 | Exercise | 16.99K | $326K | 2026-06-05 | 2026-06-08 |
Radovich Peter PRESIDENT AND COO · Stock Option (right to buy) · 2026-06-05 | Exercise | 16.99K | $0 | 2026-06-05 | 2026-06-08 |
SEC filings
EDGAR filings in MIRM · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.